Wojciech Tomczak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wojciech Tomczak has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Wojciech Krajewski
Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland
9 shared publications Bartosz Małkiewicz
University Centre of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
7 shared publicationsJan Łaszkiewicz
Department of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
7 shared publicationsJoanna Chorbińska
University Centre of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
7 shared publicationsTomasz Szydełko
Department of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
7 shared publicationsŁukasz Nowak
University Centre of Excellence in Urology, Wroclaw Medical University, Wroclaw, Poland
7 shared publications
Latest Publications
- Open Access
Quantitative Shear-Wave Elastography in Prostate Cancer: Lesion-Level Stiffness Thresholds and Association with Histopathological Aggressiveness
Background/Objectives: Quantitative shear-wave elastography (SWE) may characterize prostate lesions, but diagnostic thresholds and associations with tumor grade remain uncertain. We evaluated lesion-level thresholds for prostate cancer (PCa) and clinically significant PCa (csPCa) using mean (Emean) and maximum (Emax) Young’s modulus and examined associations with histological grade. Methods: This retrospective analysis of prospectively acquired SWE included 166 histopathologically mapped PCa foci from 132 men undergoing radical prostatectomy. Emean and Emax were measured in cancer foci and matched contralateral benign mirror regions using whole-mount histopathology-guided regions of interest. Receiver operating characteristic (ROC) analysis yielded Youden thresholds, with patient-level cluster bootstrap and out-of-bag internal validation. Adjusted ordinal models examined associations with International Society of Urological Pathology Grade Group (GG). Results: Mean lesion-to-mirror differences were 22.33 kilopascals (kPa) for Emean and 31.73 kPa for Emax. For PCa versus benign mirror tissue, areas under the ROC curve (AUCs) were 0.765 and 0.797, with respective thresholds of 54.5 and 75.5 kPa (p < 0.001 for the AUC difference). For csPCa (137 GG ≥ 2 foci) versus 29 GG1 lesions and 166 benign mirror tissues, AUCs were 0.750 and 0.771, with thresholds of 54.5 and 77.5 kPa (p = 0.010). In cancer-only comparisons (GG ≥ 2 versus GG1), discrimination was limited (Emean AUC 0.595, 95% CI 0.492–0.699; Emax AUC 0.583, 95% CI 0.478–0.685). Stiffness correlated positively with GG in unadjusted analyses, but neither absolute stiffness nor lesion-to-mirror differences were independently associated with GG after adjustment for lesion size, zone, and prostate volume; lesion size remained associated. Conclusions: SWE showed moderate discrimination in retrospectively mapped lesions, with a small advantage for Emax. Prospective external validation is required before these thresholds can be considered for clinical use.
Open AccessQuantitative Shear-Wave Elastography in Prostate Cancer: Lesion-Level Stiffness Thresholds and Association with Histopathological Aggressiveness
Background/Objectives: Quantitative shear-wave elastography (SWE) may characterize prostate lesions, but diagnostic thresholds and associations with tumor grade remain uncertain. We evaluated lesion-level thresholds for prostate cancer (PCa) and clinically significant PCa (csPCa) using mean (Emean) and maximum (Emax) Young’s modulus and examined associations with histological grade. Methods: This retrospective analysis of prospectively acquired SWE included 166 histopathologically mapped PCa foci from 132 men undergoing radical prostatectomy. Emean and Emax were measured in cancer foci and matched contralateral benign mirror regions using whole-mount histopathology-guided regions of interest. Receiver operating characteristic (ROC) analysis yielded Youden thresholds, with patient-level cluster bootstrap and out-of-bag internal validation. Adjusted ordinal models examined associations with International Society of Urological Pathology Grade Group (GG). Results: Mean lesion-to-mirror differences were 22.33 kilopascals (kPa) for Emean and 31.73 kPa for Emax. For PCa versus benign mirror tissue, areas under the ROC curve (AUCs) were 0.765 and 0.797, with respective thresholds of 54.5 and 75.5 kPa (p < 0.001 for the AUC difference). For csPCa (137 GG ≥ 2 foci) versus 29 GG1 lesions and 166 benign mirror tissues, AUCs were 0.750 and 0.771, with thresholds of 54.5 and 77.5 kPa (p = 0.010). In cancer-only comparisons (GG ≥ 2 versus GG1), discrimination was limited (Emean AUC 0.595, 95% CI 0.492–0.699; Emax AUC 0.583, 95% CI 0.478–0.685). Stiffness correlated positively with GG in unadjusted analyses, but neither absolute stiffness nor lesion-to-mirror differences were independently associated with GG after adjustment for lesion size, zone, and prostate volume; lesion size remained associated. Conclusions: SWE showed moderate discrimination in retrospectively mapped lesions, with a small advantage for Emax. Prospective external validation is required before these thresholds can be considered for clinical use.
- Open Access
Intraoperative Techniques Aiding Margin Assessment and Nerve Sparing During Robot-Assisted Radical Prostatectomy
Robot-assisted radical prostatectomy (RARP) requires a balance between complete cancer excision and preservation of urinary continence and erectile function. Because the preservation of neurovascular bundles adjacent to the prostate surface contributes to postoperative functional recovery, intraoperative margin assessment and surgeon-guidance technologies may help refine resection and support individualized nerve-sparing decision-making. Neurovascular structure-adjacent frozen-section examination remains the most studied and clinically established method, with evidence supporting reduced positive surgical margins and broader nerve preservation, but its use is limited by cost, workflow complexity, and pathology infrastructure. Fluorescence confocal microscopy is promising but remains limited by short and apical margins; its improved accuracy for longer margins raises concerns about its reliability for routine intraoperative margin assessment. Other optical, spectroscopic, and prostate-specific membrane antigen-targeted molecular margin assessment techniques have demonstrated inconsistent diagnostic performance, with particularly low sensitivity for assessment approaches remain investigational, whereas intraoperative ultrasound, three-dimensional and augmented-reality models, fluorescence guidance, and image-enhancement systems should be viewed as surgical guidance tools rather than direct margin-assessment methods. Intraoperative technologies may improve surgical decision-making during RARP, but prospective multicenter studies with standardized oncological and functional endpoints are needed before broader adoption.
Open AccessIntraoperative Techniques Aiding Margin Assessment and Nerve Sparing During Robot-Assisted Radical Prostatectomy
Robot-assisted radical prostatectomy (RARP) requires a balance between complete cancer excision and preservation of urinary continence and erectile function. Because the preservation of neurovascular bundles adjacent to the prostate surface contributes to postoperative functional recovery, intraoperative margin assessment and surgeon-guidance technologies may help refine resection and support individualized nerve-sparing decision-making. Neurovascular structure-adjacent frozen-section examination remains the most studied and clinically established method, with evidence supporting reduced positive surgical margins and broader nerve preservation, but its use is limited by cost, workflow complexity, and pathology infrastructure. Fluorescence confocal microscopy is promising but remains limited by short and apical margins; its improved accuracy for longer margins raises concerns about its reliability for routine intraoperative margin assessment. Other optical, spectroscopic, and prostate-specific membrane antigen-targeted molecular margin assessment techniques have demonstrated inconsistent diagnostic performance, with particularly low sensitivity for assessment approaches remain investigational, whereas intraoperative ultrasound, three-dimensional and augmented-reality models, fluorescence guidance, and image-enhancement systems should be viewed as surgical guidance tools rather than direct margin-assessment methods. Intraoperative technologies may improve surgical decision-making during RARP, but prospective multicenter studies with standardized oncological and functional endpoints are needed before broader adoption.
- Open Access
PSA Density and PIRADS 5 Lesions as Key Determinants of Upstaging After Radical Prostatectomy
Introduction: Clinical staging based on digital rectal examination is imprecise, leading to pathological upstaging in patients with prostate cancer (PCa). Accurate preoperative assessment remains a challenge despite the use of multiparametric magnetic resonance imaging (mpMRI) and fusion-guided biopsy. This study aims to identify key predictors of upstaging in preoperative patients. Materials and Methods: A retrospective analysis of 924 patients who underwent radical prostatectomy between July 2012 and January 2025 was performed. Variables included prostate-specific antigen, prostate volume, biopsy type, MRI, body mass index and age. Upstaging was defined as ≥pT3 in patients staged clinically as cT1–2. Optimal cut-offs for continuous variables were defined statistically. Multivariable logistic regression was applied to identify independent predictors of upstaging and minor staging upgrading (MSU)—defined as any upward shift in the pathological T stage relative to the clinical T stage. Model performance was evaluated using the area under the Receiver Operating Characteristic (ROC) curve (AUC). Results: Upstaging occurred in 31.9% and MSU in 50.6% of patients. The mean age was 65 years. Cut-off values for PSA density (PSAD) were 0.29 for upstaging and 0.28 for MSU. In the full-cohort model (AUC = 0.628), PSAD (odds ratio (OR) = 2.55), age (OR = 1.04), and hypertension (HT) (OR = 1.47) were associated with upstaging. In PIRADS-based models, PIRADS 5 and PSAD predicted both upstaging (OR = 1.62 and 6.10, respectively; AUC = 0.664) and MSU (OR = 1.75 and 4.67, respectively; AUC = 0.659). MSU was also associated with HT and a lack of fusion biopsy (AUC = 0.622). Conclusions: PSAD and PIRADS 5 lesions are strong determinants of pathological upstaging and MSU in PCa. These factors should be considered in preoperative risk stratification to improve staging accuracy. Despite advances in imaging and biopsy techniques, upstaging remains a common phenomenon, underlining the need for further refinement of diagnostic protocols.
Open AccessPSA Density and PIRADS 5 Lesions as Key Determinants of Upstaging After Radical Prostatectomy
Introduction: Clinical staging based on digital rectal examination is imprecise, leading to pathological upstaging in patients with prostate cancer (PCa). Accurate preoperative assessment remains a challenge despite the use of multiparametric magnetic resonance imaging (mpMRI) and fusion-guided biopsy. This study aims to identify key predictors of upstaging in preoperative patients. Materials and Methods: A retrospective analysis of 924 patients who underwent radical prostatectomy between July 2012 and January 2025 was performed. Variables included prostate-specific antigen, prostate volume, biopsy type, MRI, body mass index and age. Upstaging was defined as ≥pT3 in patients staged clinically as cT1–2. Optimal cut-offs for continuous variables were defined statistically. Multivariable logistic regression was applied to identify independent predictors of upstaging and minor staging upgrading (MSU)—defined as any upward shift in the pathological T stage relative to the clinical T stage. Model performance was evaluated using the area under the Receiver Operating Characteristic (ROC) curve (AUC). Results: Upstaging occurred in 31.9% and MSU in 50.6% of patients. The mean age was 65 years. Cut-off values for PSA density (PSAD) were 0.29 for upstaging and 0.28 for MSU. In the full-cohort model (AUC = 0.628), PSAD (odds ratio (OR) = 2.55), age (OR = 1.04), and hypertension (HT) (OR = 1.47) were associated with upstaging. In PIRADS-based models, PIRADS 5 and PSAD predicted both upstaging (OR = 1.62 and 6.10, respectively; AUC = 0.664) and MSU (OR = 1.75 and 4.67, respectively; AUC = 0.659). MSU was also associated with HT and a lack of fusion biopsy (AUC = 0.622). Conclusions: PSAD and PIRADS 5 lesions are strong determinants of pathological upstaging and MSU in PCa. These factors should be considered in preoperative risk stratification to improve staging accuracy. Despite advances in imaging and biopsy techniques, upstaging remains a common phenomenon, underlining the need for further refinement of diagnostic protocols.
- Open Access
- 23 December 2025
- Published by Springer Nature in Artificial Intelligence Review
- Vol. 59 (2)
The quality of AI-generated answers for patient inquiries on urolithiasis: a comparative study of ChatGPT and Deepseek
- 23 December 2025
- Published by Springer Nature in Artificial Intelligence Review
- Vol. 59 (2)
Open AccessThe quality of AI-generated answers for patient inquiries on urolithiasis: a comparative study of ChatGPT and Deepseek
- Open Access
- 25 August 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-9
Feasibility and safety of 6.3 Fr vs. 7.5 Fr digital disposable ureteroscopes in retrograde intrarenal surgery: a prospective randomised trial
Introduction Flexible ureterorenoscopy has become one of the cornerstones of minimally invasive treatment for nephrolithiasis. One of the most critical variables in scope design is the outer diameter, improving accessibility. Recently introduced 6.3 Fr ultra-slim digital ureteroscopes may offer clinical advantages over bigger scopes, but there is no data on their performance. Objectives This study aimed to prospectively compare the feasibility, safety, durability, and procedural outcomes of RIRS performed using 6.3 Fr and 7.5 Fr digital disposable ureteroscopes from the same manufacturer, evaluating intraoperative parameters, image quality, access rates, and early postoperative results. Material and methods Thirty adult patients with renal stones < 1.5 cm or cumulative volume < 850 mm³ were enrolled in a single-centre, randomised, prospective trial. All procedures were performed by a single experienced urologist using CE-certified digital disposable ureteroscopes. Lithotripsy was conducted with a high-power holmium laser and a 272-micron fiber. Subjective evaluations of manoeuvrability and image quality were recorded using 5-point Likert scales. Operator workload was assessed with NASA Task Load Index. In-vitro deflection range and image quality were measured before and after clinical use. Postoperative outcomes, complications, and intraoperative stone-free rates were recorded. Results Baseline characteristics were comparable between groups not showing major differences. Ureteral access sheaths were used in 47% of cases. Endoscope insertion into the kidney was successful in all patients. Lithotripsy was complete in 87% of cases using the 6.3 Fr scope and 73% with the 7.5 Fr scope. No statistically significant differences were found in image quality or manoeuvrability scores. Both devices allowed access to the lower pole with and without a working channel instrument. No intraoperative device failures occurred, and postoperative deflection loss was minor and infrequent. One patient required prolonged hospitalisation due to infection while all remaining patients were discharged within 24 h. No ureteral injuries or complications exceeding Clavien-Dindo grade II were observed. Conclusions The results of this study indicate that the 6.3 Fr ultra-slim ureteroscope is a feasible and safe alternative to the bigger 7.5 Fr model, with no compromise in visualisation, manoeuvrability, or device integrity. Given its comparable performance and potential for reduced ureteral trauma, the ultra-slim scope may serve as a valuable tool in modern endourology.
- 25 August 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-9
Open AccessFeasibility and safety of 6.3 Fr vs. 7.5 Fr digital disposable ureteroscopes in retrograde intrarenal surgery: a prospective randomised trial
Introduction Flexible ureterorenoscopy has become one of the cornerstones of minimally invasive treatment for nephrolithiasis. One of the most critical variables in scope design is the outer diameter, improving accessibility. Recently introduced 6.3 Fr ultra-slim digital ureteroscopes may offer clinical advantages over bigger scopes, but there is no data on their performance. Objectives This study aimed to prospectively compare the feasibility, safety, durability, and procedural outcomes of RIRS performed using 6.3 Fr and 7.5 Fr digital disposable ureteroscopes from the same manufacturer, evaluating intraoperative parameters, image quality, access rates, and early postoperative results. Material and methods Thirty adult patients with renal stones < 1.5 cm or cumulative volume < 850 mm³ were enrolled in a single-centre, randomised, prospective trial. All procedures were performed by a single experienced urologist using CE-certified digital disposable ureteroscopes. Lithotripsy was conducted with a high-power holmium laser and a 272-micron fiber. Subjective evaluations of manoeuvrability and image quality were recorded using 5-point Likert scales. Operator workload was assessed with NASA Task Load Index. In-vitro deflection range and image quality were measured before and after clinical use. Postoperative outcomes, complications, and intraoperative stone-free rates were recorded. Results Baseline characteristics were comparable between groups not showing major differences. Ureteral access sheaths were used in 47% of cases. Endoscope insertion into the kidney was successful in all patients. Lithotripsy was complete in 87% of cases using the 6.3 Fr scope and 73% with the 7.5 Fr scope. No statistically significant differences were found in image quality or manoeuvrability scores. Both devices allowed access to the lower pole with and without a working channel instrument. No intraoperative device failures occurred, and postoperative deflection loss was minor and infrequent. One patient required prolonged hospitalisation due to infection while all remaining patients were discharged within 24 h. No ureteral injuries or complications exceeding Clavien-Dindo grade II were observed. Conclusions The results of this study indicate that the 6.3 Fr ultra-slim ureteroscope is a feasible and safe alternative to the bigger 7.5 Fr model, with no compromise in visualisation, manoeuvrability, or device integrity. Given its comparable performance and potential for reduced ureteral trauma, the ultra-slim scope may serve as a valuable tool in modern endourology.
- Open Access
- 1 January 2025
- Published by Polskie Towarzystwo Urologiczne in Central European Journal of Urology
- Vol. 78 (3) , 401-405
The clinical utility of urolithiasis morphology assessment for perioperative stone composition determination
The Central European Journal of Urology is an open access quarterly-issued journal, which provides a forum for the presentation of original clinical, experimental and other research studies...
- 1 January 2025
- Published by Polskie Towarzystwo Urologiczne in Central European Journal of Urology
- Vol. 78 (3) , 401-405
Open AccessThe clinical utility of urolithiasis morphology assessment for perioperative stone composition determination
The Central European Journal of Urology is an open access quarterly-issued journal, which provides a forum for the presentation of original clinical, experimental and other research studies...
- Open Access
- 12 November 2024
- Published by Termedia Sp. z.o.o. in Polish Journal of Radiology
- Vol. 89, 526-530
Percutaneous cryoablation of renal tumours under computed tomography guidance: methodology of the procedure
Purpose: The incidence of renal cell carcinoma has been steadily increasing over the past two decades, raising the need for minimally invasive approaches. We sought to present the methodology of the percutaneous cryoablation (PCA) procedure developed based on one year of experience with 81 PCA procedures.Material and methods: The percutaneous cryoablation programme at Wroclaw Medical University Hospital has been successfully operating for a year. During this period, patients who were ineligible for partial nephrectomy either because of numerous comorbidities or strong preference against surgery were treated with PCA. Each procedure was conducted with the close cooperation of an interventional radiologist and a urologist.Results: Over the past year, 81 procedures in 74 individuals have been performed and thoroughly analysed. The mean and median effective radiation doses were 12.57 mSv and 10.76 mSv, respectively. Comprehensive details of our workflow are described within the body of the manuscript.Conclusions: Percutaneous cryoablation is a technically effective treatment approach for carefully selected individuals with small renal masses. However, starting a PCA programme from scratch necessitates creation of detailed protocols, as well as close interventional radiologist and urologist cooperation. This review outlines the established workflow and shares insights gained from one year of experience with percutaneous cryoablation.
- 12 November 2024
- Published by Termedia Sp. z.o.o. in Polish Journal of Radiology
- Vol. 89, 526-530
Open AccessPercutaneous cryoablation of renal tumours under computed tomography guidance: methodology of the procedure
Purpose: The incidence of renal cell carcinoma has been steadily increasing over the past two decades, raising the need for minimally invasive approaches. We sought to present the methodology of the percutaneous cryoablation (PCA) procedure developed based on one year of experience with 81 PCA procedures.Material and methods: The percutaneous cryoablation programme at Wroclaw Medical University Hospital has been successfully operating for a year. During this period, patients who were ineligible for partial nephrectomy either because of numerous comorbidities or strong preference against surgery were treated with PCA. Each procedure was conducted with the close cooperation of an interventional radiologist and a urologist.Results: Over the past year, 81 procedures in 74 individuals have been performed and thoroughly analysed. The mean and median effective radiation doses were 12.57 mSv and 10.76 mSv, respectively. Comprehensive details of our workflow are described within the body of the manuscript.Conclusions: Percutaneous cryoablation is a technically effective treatment approach for carefully selected individuals with small renal masses. However, starting a PCA programme from scratch necessitates creation of detailed protocols, as well as close interventional radiologist and urologist cooperation. This review outlines the established workflow and shares insights gained from one year of experience with percutaneous cryoablation.
- Open Access
- 25 October 2024
- Published by "Medycyna Praktyczna" Spolka Jawna in Videosurgery and Other Miniinvasive Techniques
- Vol. 19 (4) , 483-488
Percutaneous cryoablation of kidney tumors after partial nephrectomy
DOI: 10.20452/wiitm.2024.17904, Published online: October 25, 2024, Authors: Wojciech Krajewski1, Maciej Guziński2, Wojciech Tomczak3, Łukasz Nowak1, Jan Łaszkiewicz3, Joanna Chorbińska1, Adam Chełmoński3, Katarzyna Grunwald3, Bartosz Małkiewicz1, Tomasz Szydełko3
- 25 October 2024
- Published by "Medycyna Praktyczna" Spolka Jawna in Videosurgery and Other Miniinvasive Techniques
- Vol. 19 (4) , 483-488
Open AccessPercutaneous cryoablation of kidney tumors after partial nephrectomy
DOI: 10.20452/wiitm.2024.17904, Published online: October 25, 2024, Authors: Wojciech Krajewski1, Maciej Guziński2, Wojciech Tomczak3, Łukasz Nowak1, Jan Łaszkiewicz3, Joanna Chorbińska1, Adam Chełmoński3, Katarzyna Grunwald3, Bartosz Małkiewicz1, Tomasz Szydełko3
- Open Access
- 23 October 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 42 (1) , 1-8
Polish validation of the wisconsin stone quality of life questionnaire (POL-WISQoL)
Purpose: Urolithiasis significantly affects patient quality of life, yet the global standard of care predominantly focuses on achieving a stone free status, often ignoring patient reported outcomes. Currently, there are no specific measures available to assess the quality of life in the Polish population suffering from kidney stones. Therefore, this study aimed to develop and validate the Polish version of the Wisconsin Stone Quality of Life Questionnaire. Methods: The translation of WISQOL was carried out in accordance with the best available guidelines. Patients treated for kidney stones at a tertiary centre were recruited and completed both POL-WISQOL and SF36 questionnaires. Comprehensive analyses were conducted to assess internal consistency, inter-item and inter-domain correlations, as well as convergent and construct validity. Additionally, test-retest reliability was evaluated to ensure the accuracy and stability of the findings. Results: A total of 102 participants fully completed both questionnaires and were included in the analysis. The translated survey demonstrated excellent internal consistency (Cronbach’s coefficient 0.967) and significant convergent validity (Spearman’s correlation = 0.847, p < 0.001). Furthermore, an ANOVA with Tukey’s post hoc analysis revealed a significant decline in WISQOL scores between symptomatic and asymptomatic individuals, thereby confirming tool’s construct validity. Conclusion: POL-WISQoL turned out to be a valid disease specific health related quality of life measuring tool. Its widespread utilisation has the potential to shift the standard of care towards patient centered outcomes.
- 23 October 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 42 (1) , 1-8
Open AccessPolish validation of the wisconsin stone quality of life questionnaire (POL-WISQoL)
Purpose: Urolithiasis significantly affects patient quality of life, yet the global standard of care predominantly focuses on achieving a stone free status, often ignoring patient reported outcomes. Currently, there are no specific measures available to assess the quality of life in the Polish population suffering from kidney stones. Therefore, this study aimed to develop and validate the Polish version of the Wisconsin Stone Quality of Life Questionnaire. Methods: The translation of WISQOL was carried out in accordance with the best available guidelines. Patients treated for kidney stones at a tertiary centre were recruited and completed both POL-WISQOL and SF36 questionnaires. Comprehensive analyses were conducted to assess internal consistency, inter-item and inter-domain correlations, as well as convergent and construct validity. Additionally, test-retest reliability was evaluated to ensure the accuracy and stability of the findings. Results: A total of 102 participants fully completed both questionnaires and were included in the analysis. The translated survey demonstrated excellent internal consistency (Cronbach’s coefficient 0.967) and significant convergent validity (Spearman’s correlation = 0.847, p < 0.001). Furthermore, an ANOVA with Tukey’s post hoc analysis revealed a significant decline in WISQOL scores between symptomatic and asymptomatic individuals, thereby confirming tool’s construct validity. Conclusion: POL-WISQoL turned out to be a valid disease specific health related quality of life measuring tool. Its widespread utilisation has the potential to shift the standard of care towards patient centered outcomes.
- Open Access
- 31 August 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (17) , 1927
Blood-, Tissue- and Urine-Based Prognostic Biomarkers of Upper Tract Urothelial Carcinoma
Upper tract urothelial carcinoma (UTUC) is a rare but aggressive neoplasm. Currently, there are few reliable and widely used prognostic biomarkers of this disease. The purpose of this study was to assess the prognostic value of blood-, tissue- and urine-based biomarkers in patients with UTUC. A comprehensive literature search was conducted using the PubMed, Cochrane and Embase databases. Case reports, editorials and non-peer-reviewed literature were excluded from the analysis. As a result, 94 articles were included in this review. We evaluated the impact of 22 blood-based, 13 tissue-based and 4 urine-based biomarkers and their influence on survival outcomes. The neutrophil–lymphocyte ratio, albumin, C-reactive protein, De Ritis ratio, renal function and fibrinogen, which are currently mentioned in the European Association of Urology (EAU) guidelines, are well researched and most probably allow for a reliable prognosis estimate. However, our review highlights a number of other promising biomarkers that could potentially predict oncological outcomes in patients with UTUC. Nonetheless, the clinical value of some prognostic factors remains uncertain due to the lack of comprehensive studies.
- 31 August 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (17) , 1927
Open AccessBlood-, Tissue- and Urine-Based Prognostic Biomarkers of Upper Tract Urothelial Carcinoma
Upper tract urothelial carcinoma (UTUC) is a rare but aggressive neoplasm. Currently, there are few reliable and widely used prognostic biomarkers of this disease. The purpose of this study was to assess the prognostic value of blood-, tissue- and urine-based biomarkers in patients with UTUC. A comprehensive literature search was conducted using the PubMed, Cochrane and Embase databases. Case reports, editorials and non-peer-reviewed literature were excluded from the analysis. As a result, 94 articles were included in this review. We evaluated the impact of 22 blood-based, 13 tissue-based and 4 urine-based biomarkers and their influence on survival outcomes. The neutrophil–lymphocyte ratio, albumin, C-reactive protein, De Ritis ratio, renal function and fibrinogen, which are currently mentioned in the European Association of Urology (EAU) guidelines, are well researched and most probably allow for a reliable prognosis estimate. However, our review highlights a number of other promising biomarkers that could potentially predict oncological outcomes in patients with UTUC. Nonetheless, the clinical value of some prognostic factors remains uncertain due to the lack of comprehensive studies.